IBRX logo

Immunitybio Inc (IBRX)

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion pr...

NASDAQHealthcareBiotechnologyUSA

公司簡介

股票程式碼
IBRX
ISIN程式碼
US45256X1037
貨幣
US Dollar (USD)
IPO日期
2015-07-28

聯絡資訊

公司地址
3530 John Hopkins Court, San Diego, CA, United States, 92121
聯絡電話
844 696 5235
公司網站
https://immunitybio.com
財年結束
December

財務亮點

市值
$999,999.99
毛利潤(TTM)
$999,999.99
資產回報率(TTM)
-30.54%
EBITDA
$-999,999.99
收入(TTM)
$999,999.99